Norvasc (Amlodipine)

Amlodipine blocks L‑type calcium channels in vascular smooth muscle and cardiac cells. This inhibition prevents calcium entry, causing arterial vasodilation, reduced peripheral resistance, and a modest decrease in cardiac contractility, which together lower blood pressure and myocardial oxygen demand.

The prescribed dose of Norvasc is individualized by the treating physician based on the patient’s blood‑pressure readings, clinical response, and tolerability. Typical starting doses range from low to moderate strength, with adjustments made as needed under medical supervision.

Safety data for amlodipine in pregnancy are limited, and the drug should only be used if the potential benefit justifies the potential risk to the fetus. Regarding breastfeeding, amlodipine is excreted in small amounts in milk; a decision should be made after weighing maternal benefits against possible infant exposure.

To request Norvasc, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with ACE inhibitors or ARBs, amlodipine offers a once‑daily oral regimen with a low incidence of cough and hyperkalemia. Unlike short‑acting dihydropyridines such as nifedipine, amlodipine has a longer half‑life, providing smoother blood‑pressure control and fewer peaks that can cause reflex tachycardia.

Store Norvasc tablets at ambient temperature, preferably below 25 °C, in the original blister pack or container. Protect the product from moisture, excessive heat, and direct sunlight to maintain stability throughout its shelf life.

Norvasc is taken orally as a whole tablet with or without food. Swallow the tablet whole with a glass of water; do not crush, chew, or split unless specifically instructed by a healthcare professional.

Serious adverse events, although rare, include severe hypotension, myocardial infarction, hepatic dysfunction, severe allergic reactions such as angioedema, and cardiac conduction disturbances like heart block. Patients should seek immediate medical attention if they experience symptoms such as fainting, chest pain, jaundice, or unexplained swelling.

Norvasc is contraindicated in patients with known hypersensitivity to amlodipine or any other dihydropyridine calcium channel blocker. Caution is advised in individuals with severe aortic stenosis, unstable heart failure, or those taking potent CYP3A4 inhibitors that could markedly increase drug levels.